Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
As restructuring professionals, we are all aware of the numerous factors that are weighing down the global economy: inflation, the war in Ukraine, rising interest rates, and the COVID-19 pandemic. Now it’s time to add to that list the threat of the United States running out of money and defaulting on its debts. This inconceivable event could occur when the country hits its debt ceiling, something that could potentially come to pass this summer.
Breaching the debt ceiling is avoidable as Congress could increase the statutory limit on US debt, but at a moment of heightened partisanship and divided government accomplishing that will be challenging. As suggested by the New York Times, “the cost of not raising the borrowing cap could be catastrophic, causing a deep recession in the United States and potentially prompting a global financial crisis.”
While we all hope the US Congress figures a way out of this crisis, staying current on restructuring options around the world remains essential. We help you do that in our current issue as we review hot topics in a variety of jurisdictions around the globe where our lawyers practice.
And I would be remise in not congratulating those same lawyers in recently being recognized as one of the top 10 law firms for cross-border restructuring work in 2022 by the Global Restructuring Review (GRR)!
Good reading,
Howard Seife
Global Co-Head of Restructuring
New York
Scott Atkins
Global Co-Head of Restructuring
Sydney
Publication
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023